Takako Sasaki

Dr. Takako Sasaki

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Blood
Verified
Journal Article
Open access
PDF file
HCHuan Cai
Huan Cai
MKMakoto Kondo
Makoto Kondo
LSLakshmi Sandhow
Lakshmi Sandhow
PXPingnan Xiao
Pingnan Xiao
AJAnne-Sofie Johansson
Anne-Sofie Johansson
HQHong Qian
Hong Qian
Impairment of normal hematopoiesis and leukemia progression are 2 well-linked processes during leukemia development and are controlled by the bone marrow (BM) niche. Extracellular matrix proteins, including laminin, are important BM niche components. However, their role in hematopoiesis regeneration and leukemia is unknown. Laminin α4 (Lama4), a major receptor-binding chain of several laminins, is altered in BM niches in mice with acute myeloid leukemia (AML). So far, the impact of Lama4 on leukemia progression remains unknown. We here report that Lama4 deletion in mice resulted in impaired hematopoiesis regeneration following irradiation-induced stress, which is accompanied by altered BM niche composition and inflammation. Importantly, in a transplantation-induced MLL-AF9 AML mouse model, we demonstrate accelerated AML progression and relapse in Lama4−/− mice. Upon AML exposure, Lama4−/− mesenchymal stem cells (MSCs) exhibited dramatic molecular alterations, including upregulation of inflammatory cytokines that favor AML growth. Lama4−/− MSCs displayed increased antioxidant activities and promoted AML stem cell proliferation and chemoresistance to cytarabine, which was accompanied by increased mitochondrial transfer from the MSCs to AML cells and reduced reactive oxygen species in AML cells in vitro. Similarly, we detected lower levels of reactive oxygen species in AML cells from Lama4−/− mice post–cytarabine treatment. Notably, LAMA4 inhibition or knockdown in human MSCs promoted human AML cell proliferation and chemoprotection. Together, our study for the first time demonstrates the critical role of Lama4 in impeding AML progression and chemoresistance. Targeting Lama4 signaling pathways may offer potential new therapeutic options for AML.

1 February 2017 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
EUEriko Uehara
Eriko Uehara
HHHideki Hokazono
Hideki Hokazono
TSTakako Sasaki
Takako Sasaki
HYHidekatsu Yoshioka
Hidekatsu Yoshioka
NMNoritaka Matsuo
Noritaka Matsuo
We examined the effects of GABA on type I collagen gene expression in normal human dermal fibroblasts. Real-time PCR analysis indicated GABA increased the level of type I collagen transcripts, and suppressed the expression of matrix metalloproteinase-1, which is a collagen-degrading enzyme. These results suggest GABA improves the skin elasticity by regulating type I collagen expression.

Verified
Journal Article
Open access
PDF file
MKMiho Kuwahara
Miho Kuwahara
KKKoichi Kadoya
Koichi Kadoya
SKSei Kondo
Sei Kondo
SFShanqi Fu
Shanqi Fu
YMYoshiko Miyake
Yoshiko Miyake
THTakako Hattori
Takako Hattori
Aging is a major risk factor of osteoarthritis, which is characterized by the degeneration of articular cartilage. CCN3, a member of the CCN family, is expressed in cartilage and has various physiological functions during chondrocyte development, differentiation, and regeneration. Here, we examine the role of CCN3 in cartilage maintenance. During aging, the expression of Ccn3 mRNA in mouse primary chondrocytes from knee cartilage increased and showed a positive correlation with p21 and p53 mRNA. Increased accumulation of CCN3 protein was confirmed. To analyze the effects of CCN3 in vitro, either primary cultured human articular chondrocytes or rat chondrosarcoma cell line (RCS) were used. Artificial senescence induced by H2O2 caused a dose-dependent increase in Ccn3 gene and CCN3 protein expression, along with enhanced expression of p21 and p53 mRNA and proteins, as well as SA-β gal activity. Overexpression of CCN3 also enhanced p21 promoter activity via p53. Accordingly, the addition of recombinant CCN3 protein to the culture increased the expression of p21 and p53 mRNAs. We have produced cartilage-specific CCN3-overexpressing transgenic mice, and found degradative changes in knee joints within two months. Inflammatory gene expression was found even in the rib chondrocytes of three-month-old transgenic mice. Similar results were observed in human knee articular chondrocytes from patients at both mRNA and protein levels. These results indicate that CCN3 is a new senescence marker of chondrocytes, and the overexpression of CCN3 in cartilage may in part promote chondrocyte senescence, leading to the degeneration of articular cartilage through the induction of p53 and p21.

5 July 2024 in Science Advances
Verified
Journal Article
Open access
BPBrooke Pereira
Brooke Pereira
SRShona Ritchie
Shona Ritchie
CCCecilia R. Chambers
Cecilia R. Chambers
KGKatie A. Gordon
Katie A. Gordon
AMAstrid Magenau
Astrid Magenau
PTPaul Timpson
Paul Timpson
Pancreatic ductal adenocarcinoma (PDAC) is characterized by increasing fibrosis, which can enhance tumor progression and spread. Here, we undertook an unbiased temporal assessment of the matrisome of the highly metastatic KPC ( Pdx1-Cre , LSL-Kras G12D/+ , LSL-Trp53 R172H/+ ) and poorly metastatic KP fl C ( Pdx1-Cre , LSL-Kras G12D/+ , Trp53 fl/+ ) genetically engineered mouse models of pancreatic cancer using mass spectrometry proteomics. Our assessment at early-, mid-, and late-stage disease reveals an increased abundance of nidogen-2 (NID2) in the KPC model compared to KP fl C, with further validation showing that NID2 is primarily expressed by cancer-associated fibroblasts (CAFs). Using biomechanical assessments, second harmonic generation imaging, and birefringence analysis, we show that NID2 reduction by CRISPR interference (CRISPRi) in CAFs reduces stiffness and matrix remodeling in three-dimensional models, leading to impaired cancer cell invasion. Intravital imaging revealed improved vascular patency in live NID2-depleted tumors, with enhanced response to gemcitabine/Abraxane. In orthotopic models, NID2 CRISPRi tumors had less liver metastasis and increased survival, highlighting NID2 as a potential PDAC cotarget.

1 March 2016 in Matrix Biology
Verified
Journal Article
Closed access
TSTakako Sasaki
Takako Sasaki
RSReinout Stoop
Reinout Stoop
TSTakao Sakai
Takao Sakai
AHAndreas Hess
Andreas Hess
RDRainer Deutzmann
Rainer Deutzmann
KMKlaus von der Mark
Klaus von der Mark

1 December 2016 in Matrix Biology
Verified
Journal Article
Closed access
TSTakako Sasaki
Takako Sasaki
FHFranz-Georg Hanisch
Franz-Georg Hanisch
RDRainer Deutzmann
Rainer Deutzmann
LSLynn Y. Sakai
Lynn Y. Sakai
Tetsushi SakumaTetsushi Sakuma
Tetsushi Sakuma
KMKlaus von der Mark
Klaus von der Mark